Cargando…
Where are we in 2021 with heart failure with reduced ejection fraction?—current outlook and expectations from new promising clinical trials
Guideline-directed optimal medical therapy is a well-established therapy in treating patients with heart failure with reduced ejection fraction (HFrEF). Despite clear recommendations, the prognosis in this group of patients is still poor with high mortality. After publishing results of the PARADIGM-...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898246/ https://www.ncbi.nlm.nih.gov/pubmed/34050489 http://dx.doi.org/10.1007/s10741-021-10120-x |